OAM
PBYI icon

Oppenheimer Asset Management’s Puma Biotechnology PBYI Stock Holding History

Oppenheimer Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,815
Closed -$209K – 1247
2021
Q3 		$209K Buy
29,815
+1,710
+6% +$12.8K ﹤0.01% 1134
2021
Q2 		$258K Sell
28,105
-10,444
-27% -$106K ﹤0.01% 1091
2021
Q1 		$375K Buy
38,549
+801
+2% +$8.95K 0.01% 985
2020
Q4 		$387K Buy
37,748
+897
+2% +$9.08K 0.01% 941
2020
Q3 		$372K Buy
36,851
+11,082
+43% +$113K 0.01% 878
2020
Q2 		$269K Buy
25,769
+8,754
+51% +$90.6K 0.01% 962
2020
Q1 		$144K Buy
17,015
+7,110
+72% +$69.1K ﹤0.01% 1037
2019
Q4 		$87K Buy
9,905
+384
+4% +$3.18K ﹤0.01% 1235
2019
Q3 		$102K Buy
9,521
+2,737
+40% +$29.6K ﹤0.01% 1182
2019
Q2 		$86K Buy
6,784
+307
+5% +$7.07K ﹤0.01% 1261
2019
Q1 		$251K Buy
6,477
+1,454
+29% +$44.4K 0.01% 978
2018
Q4 		$102K Buy
5,023
+367
+8% +$11K ﹤0.01% 1185
2018
Q3 		$213K Buy
+4,656
New +$224K ﹤0.01% 1067
2017
Q4 		– Sell
-241
Closed -$29K – 1370
2017
Q3 		$29K Sell
241
-32
-12% -$2.98K ﹤0.01% 1457
2017
Q2 		$24K Sell
273
-150
-35% -$8.39K ﹤0.01% 1459
2017
Q1 		$16K Buy
+423
New +$15.4K ﹤0.01% 1495

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Oppenheimer Asset Management's PBYI Position: Q4 2021 in Review

Oppenheimer Asset Management sold out of Puma Biotechnology (PBYI) in Q4 2021, closing a stake of 29,815 shares — an estimated $209K sold.

Oppenheimer Asset Management first reported a position in PBYI in Q1 2017 and held it in 16 quarters. The position peaked at $387K in Q4 2020. 102 funds tracked by Wall St. Rank hold PBYI as of Q4 2021.

  • Oppenheimer Asset Management reported no remaining Puma Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Oppenheimer Asset Management sold 29,815 Puma Biotechnology shares in Q4 2021, an estimated $209K.
  • Oppenheimer Asset Management first reported a position in Puma Biotechnology in Q1 2017 and held it in 16 quarters.
  • Oppenheimer Asset Management's Puma Biotechnology position peaked at $387K in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2021.

Based on Oppenheimer Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.